About Allovir (ALVR)
AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to r... Read more
- USD1.53
- USD1.56
- USD1.49
- USD7.84
- 14.90%
- --
- 43.00
- 852.87k
- 177M
- 1.31
- -79.00%
Stock News
1 hour ago
Key Words: Paris mayor leaves Elon Musk’s social-media service, calling it a ‘gigantic global sewer’
MarketWatch
1 hour ago
NLS Pharmaceutics Announces Election of Additional Board Members
Yahoo
2 hours ago
Earnings Results: PDD’s stock rockets as Temu parent crushes estimates, sees revenue nearly double
MarketWatch
2 hours ago
Help Me Retire: Will my wife’s school pension and my military retirement pay reduce our Social Security? We’ll start collecting at 70.
MarketWatch
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
